Genesystem Co., Ltd. (KOSDAQ:363250)
South Korea · Delayed Price · Currency is KRW 4,730.00
0.00 (0.00%)
At close: Jul 31, 2026
Genesystem Market Cap
Genesystem has a market cap or net worth of 39.19 billion as of July 31, 2026. Its market cap has decreased by -6.94% in one year.
Market Cap
39.19B
Enterprise Value
37.91B
Revenue
647.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
4,730.00
ChartMarket Cap Chart
Since May 26, 2021, Genesystem's market cap has decreased from 118.51B to 39.19B, a decrease of -66.93%. That is a compound annual growth rate of -19.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 39.19B | 40.16% |
| Dec 30, 2025 | 27.96B | -52.89% |
| Dec 30, 2024 | 59.36B | -8.92% |
| Dec 28, 2023 | 65.17B | 12.35% |
| Dec 29, 2022 | 58.00B | -26.36% |
| Dec 30, 2021 | 78.77B | -33.54% |
| May 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| L&K Biomed | 68.28B |
| Hironic | 63.05B |
| SELVAS Healthcare | 61.21B |
| DRGEM | 53.61B |
| JPI Healthcare | 44.42B |
| Genoray | 44.05B |
| QuantaMatrix | 42.79B |
| Noul Co.,Ltd. | 29.80B |